Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barsotti

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Arizona Medicine|September 1, 1978
HyperparathyroidismM Barsotti
Diabetes Care|July 1, 1980
Potassium phosphate and potassium chloride in the treatment of DKAM M Barsotti
Oncogene|September 15, 2009
Pro-proliferative FoxM1 is a target of p53-mediated repressionA M Barsotti, C Prives
Cell|August 10, 2010
Noncoding RNAs: the missing "linc" in p53-mediated repressionAnthony M Barsotti, Carol Prives
Nursing Outlook|September 1, 1975
Family focus--transitional health careK F Shepard, L M Barsotti
Annals of Emergency Medicine|October 1, 1996
False-positive end-tidal CO2L Montauk, A D Michaels, M Barsotti
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2008
A role for caspase 2 and PIDD in the process of p53-mediated apoptosisNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
Epigenomics|August 29, 2015
Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutationsAnthony M Barsotti, Michael Ryskin, Robert A Rollins
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent mannerNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
Pediatric Pulmonology|July 1, 1996
Transferrin modifies surfactant responsiveness in acute respiratory failure: role of iron-free transferrin as an antioxidantM Hallman, V Chundu, M Barsotti, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Arizona Medicine|September 1, 1978
HyperparathyroidismM Barsotti
Diabetes Care|July 1, 1980
Potassium phosphate and potassium chloride in the treatment of DKAM M Barsotti
Oncogene|September 15, 2009
Pro-proliferative FoxM1 is a target of p53-mediated repressionA M Barsotti, C Prives
Cell|August 10, 2010
Noncoding RNAs: the missing "linc" in p53-mediated repressionAnthony M Barsotti, Carol Prives
Nursing Outlook|September 1, 1975
Family focus--transitional health careK F Shepard, L M Barsotti
Annals of Emergency Medicine|October 1, 1996
False-positive end-tidal CO2L Montauk, A D Michaels, M Barsotti
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2008
A role for caspase 2 and PIDD in the process of p53-mediated apoptosisNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
Epigenomics|August 29, 2015
Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutationsAnthony M Barsotti, Michael Ryskin, Robert A Rollins
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent mannerNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
Pediatric Pulmonology|July 1, 1996
Transferrin modifies surfactant responsiveness in acute respiratory failure: role of iron-free transferrin as an antioxidantM Hallman, V Chundu, M Barsotti, et al.
Pageof 6